Stay updated on iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Sign up to get notified when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.

Latest updates to the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page
- Check3 days agoChange DetectedThe page footer now includes a new Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 text were removed. This update does not modify study content or user-facing information on the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page; no study details or critical information appear to have changed.SummaryDifference0.1%

- Check39 days agoChange DetectedThe site-wide notice about government funding status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedNo additions or deletions were detected for the Study Details page (NCT03498222). The content and layout remain unchanged.SummaryDifference0.3%

- Check81 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check89 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.